Czech Republic: COVID-19 patients treated with MLS®

21 January 2021 - Research -

Doctor Scott Sigman’s (an orthopaedic surgeon in Massachusetts) successful experience in using MLS® Laser Therapy in a clinical trial to treat interstitial pneumonia caused by COVID-19 has become a reference point. The significant improvement in some basic parameters (respiratory indexes, radiological results, oxygen demand) observed by the American doctor in patients who underwent MLS® sessions, have also been reported by the COVID unit of the Kolin Hospital, in Bohemia.

Please accept statistics cookies to watch this video.

Indeed, the doctors at the facility decided to use ASA’s M6 device on some patients suffering from the virus, with a more than encouraging outcome.

“After seeing the remarkable results obtained by our Massachusetts colleagues when using MLS® for treating pneumonia caused by COVID-19 –Lukáš Cibulka, the chief physician, explains – we decided that some of our cases should undergo this therapy: to date, we have treated 26 patients and seen a marked improvement for 24 of these. An evident benefit was also had by patients hospitalised for over a month, who were able to be discharged and to continue with home care after applying the protocol which includes some sessions with MLS®”.

Radiological exams to verify the lung status highlighted that after the laser therapy sessions, a substantial remission of the inflammatory alterations in the two organs and, in parallel, an improvement of the patient’s clinical picture were seen.

“Following our direct experience, we confirm the conclusions reached in America in relation to the value of MLS® for treating interstitial pneumonia caused by the virus. Its action consists in reducing the progress of the tissue inflammation, with consequences also on the pulmonary fibrotization”.

You might also be interested in ...

See all articles

press - 21/01/2021
After viewing the successful results obtained by Doctor Scott Sigman (an orthopaedic surgeon in Massachusetts) when using MLS® Laser Therapy for a clinical trial to treat interstitial pneumonia...
COVID19 case report - laser beam positioning
blog - 02/10/2020
A new case confirms the effectiveness of MLS® as supporting therapy for treating pneumonia caused by COVID-19.
MLS Laser Therapy for the treatment of COVID19 pneumonia
blog - 24/08/2020
A very recent case report concerning the use of MLS® Laser Therapy supporting a patient suffering from severe pneumonia caused by Covid-19 reported a significant improvement in some basic parameters...
ASAlaser and Asian Star @ KIMES 2024
News - 15/04/2024
Thus, the company staff once again flew to Seoul to take part in the 2024 edition of Kimes, where the flagship devices were displayed.
ASA laser training in Thailand 2024
News - 15/04/2024
Two leading Thai hospitals – Snriragarind Hospital in Khon Khaen and Buriram Hospital in Buriram – were the setting for three workshops focused on Hilterapia® and MLS® Laser Therapy organised by our...
ASA laser therapies training in Montenegro
News - 12/04/2024
Biological effects and scientific evidence concerning MLS® Laser Therapy, Magnetotherapy Qs and Hilterapia® with hands-on sessions to verify the application methods and the effectiveness of the...